Tian'an Pharmaceutical Co Ltd
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chi… Read more
Tian'an Pharmaceutical Co Ltd (TNPH) - Total Assets
Latest total assets as of December 2024: $5.71K USD
Based on the latest financial reports, Tian'an Pharmaceutical Co Ltd (TNPH) holds total assets worth $5.71K USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tian'an Pharmaceutical Co Ltd - Total Assets Trend (2004–2024)
This chart illustrates how Tian'an Pharmaceutical Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tian'an Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Tian'an Pharmaceutical Co Ltd's total assets of $5.71K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.5% |
| Accounts Receivable | $5.57K | 97.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2024)
This chart illustrates how Tian'an Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tian'an Pharmaceutical Co Ltd's current assets represent 100.0% of total assets in 2024, an increase from 73.7% in 2004.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2024, down from 28.3% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 20.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 97.5% of total assets.
Tian'an Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Tian'an Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Tian'an Pharmaceutical Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tian'an Pharmaceutical Co Ltd generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tian'an Pharmaceutical Co Ltd is currently not profitable relative to its asset base.
Tian'an Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.84 | 14.80 |
| Quick Ratio | 0.06 | 0.80 | 13.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-85.65K | $ -66.98K | $ 8.84 Million |
Tian'an Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Tian'an Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.20 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -98.4% |
| Total Assets | $5.71K |
| Market Capitalization | $17.24 USD |
Valuation Analysis
Below Book Valuation: The market values Tian'an Pharmaceutical Co Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tian'an Pharmaceutical Co Ltd's assets decreased by 98.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tian'an Pharmaceutical Co Ltd (2004–2024)
The table below shows the annual total assets of Tian'an Pharmaceutical Co Ltd from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $5.71K | -98.41% |
| 2023-12-31 | $359.59K | +4745.59% |
| 2022-12-31 | $7.42K | -98.13% |
| 2021-12-31 | $396.43K | +1824.43% |
| 2020-12-31 | $20.60K | +0.77% |
| 2019-12-31 | $20.44K | +3.36% |
| 2018-12-31 | $19.78K | -99.87% |
| 2007-12-31 | $15.38 Million | +38.82% |
| 2006-12-31 | $11.08 Million | +20.55% |
| 2005-12-31 | $9.19 Million | +57.44% |
| 2004-12-31 | $5.84 Million | -- |